Abstract
This chapter analyzes family and non-family firms’ innovative activity performance in the Italian pharmaceutical industry. By taking stock of literature on family firms and innovation management, as reviewed in Chaps. 2 and 3, it develops theoretical arguments regarding the multidimensional involvement of families in the innovative performance of Italian pharmaceutical firms, in terms of both the scale and quality of innovation. This chapter includes an empirical section that describes data sources, details the data collection process, and explains the methodology for the data analysis. It concludes by presenting and discussing the empirical findings and drawing conclusions from this evidence.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Achilladelis, B., & Antonakis, N. (2001). The dynamics of technological innovation: The case of the pharmaceutical industry. Research Policy, 30(4), 535–588.
Almeida, P., & Phene, A. (2004). Subsidiaries and knowledge creation: The influence of the MNC and host country on innovation. Strategic Management Journal, 25(8–9), 847–864.
Anderson, R. C., Duru, A., & Reeb, D. M. (2012). Investment policy in family controlled firms. Journal of Banking & Finance, 36(6), 1744–1758.
Bammens, Y., Voordeckers, W., & Van Gils, A. (2011). Boards of directors in family businesses: A literature review and research agenda. International Journal of Management Reviews, 13(2), 134–152.
Banno, M. (2016). Propensity to patent by family firms. Journal of Family Business Strategy, 7(4), 238–248.
Basu, N., Dimitrova, L., & Paeglis, I. (2009). Family control and dilution in mergers. Journal of Banking & Finance, 33(5), 829–841.
Bierly, P., & Chakrabarti, A. (1996). Generic knowledge strategies in the U.S. pharmaceutical industry. Strategic Management Journal, 17, 123–135.
Block, J. H. (2012). R&D investments in family and founder firms: An agency perspective. Journal of Business Venturing, 27(2), 248–265.
Block, J., Miller, D., Jaskiewicz, P., & Spiegel, F. (2013). Economic and technological importance of innovations in large family and founder firms: An analysis of patent data. Family Business Review, 26(2), 180–199.
Bloom, N., & Van Reenen, J. (2002). Patents, real options and firm performance. The Economic Journal, 112(478), 97–116.
Broekaert, W., Andries, P., & Debackere, K. (2016). Innovation processes in family firms: The relevance of organizational flexibility. Small Business Economics, 47(3), 771–785.
Carnes, C. M., & Ireland, R. D. (2013). Familiness and innovation: Resource bundling as the missing link. Entrepreneurship Theory and Practice, 37(6), 1399–1419.
Cassiman, B., Veugelers, R., & Zuniga, P. (2008). In search of performance effects of (in) direct industry science links. Industrial and Corporate Change, 17(4), 611–646.
Chen, H. L., & Hsu, W. T. (2009). Family ownership, board independence, and R&D investment. Family Business Review, 22(4), 347–362.
Chesbrough, H. (2006). Open innovation: A new paradigm for understanding industrial innovation. Open Innovation: Researching a New Paradigm, 400, 0–19.
Chrisman, J. J., & Patel, P. C. (2012). Variations in R&D investments of family and nonfamily firms: Behavioral agency and myopic loss aversion perspectives. Academy of Management Journal, 55(4), 976–997.
Classen, N., Carree, M., Van Gils, A., & Peters, B. (2014). Innovation in family and non-family SMEs: An exploratory analysis. Small Business Economics, 42(3), 595–609.
Cockburn, I. M., & Henderson, R. M. (2000). Publicly funded science and the productivity of the pharmaceutical industry. Innovation Policy and the Economy, 1, 1–34.
Corbetta, G., & Salvato, C. A. (2004). The board of directors in family firms: One size fits all? Family Business Review, 17(2), 119–134.
DeCarolis, D. M. (2003). Competencies and imitability in the pharmaceutical industry: An analysis of their relationship with firm performance. Journal of Management, 29, 27–50.
Duran, P., Kammerlander, N., Van Essen, M., & Zellweger, T. (2016). Doing more with less: Innovation input and output in family firms. Academy of Management Journal, 59(4), 1224–1264.
Fama, E. F. (1980). Agency problems and the theory of the firm. The Journal of Political Economy, 88(2), 288–307.
Fama, E. F., & Jensen, M. C. (1983). Agency problems and residual claims. Journal of Law and Economics, 26, 327–349.
Family Firms Institute. (2017). Family enterprise statistics from around the world. Available at: http://www.ffi.org/?page=GlobalDataPoints.
Gambardella, A. (1992). Competitive advantages from in-house scientific research: The US pharmaceutical industry in the 1980s. Research Policy, 21(5), 391–407.
Gambardella, A. (2005). Patents and the division of innovative labor. Industrial and Corporate Change, 14(6), 1223–1233.
Gambardella, A., Harhoff, D., & Verspagen, B. (2008). The value of European patents. European Management Review, 5(2), 69–84.
Gittelman, M., & Kogut, B. (2003). Does good science lead to valuable knowledge? Biotechnology firms and the evolutionary logic of citation patterns. Management Science, 49(4), 366–382.
Gomez-Mejia, L. R., Campbell, J. T., Martin, G., Hoskisson, R. E., Makri, M., & Sirmon, D. G. (2014). Socioemotional wealth as a mixed gamble: Revisiting family firm R&D investments with the behavioral agency model. Entrepreneurship Theory and Practice, 38(6), 1351–1374.
Gomez-Mejia, L. R., Haynes, K. T., Nunez-Nickel, M., Jacobson, K., & Moyano-Fuentes, J. (2007). Socioemotional wealth and business risks in family controlled firms: Evidence from Spanish olive oil mills. Administrative Science Quarterly, 52, 106–137.
Hagedoorn, J. (2003). Sharing intellectual property right: An exploratory study of joint patenting amongst companies. Industrial and Corporate Change, 12, 1035–1050.
Hall, B. R. H., & Ziedonis, A. A. (2001). The patent paradox revisited: An empirical study of patenting in the US. The Rand Journal of Economics, 32(1), 101–128.
Hall, B. H., Jaffe, A. B., & Trajtenberg, M. (2001). The NBER patent citation data file: Lessons, insights and methodological tools (No. w8498). National Bureau of Economic Research.
Hall, B. H., Jaffe, A., & Trajtenberg, M. (2005). Market value and patent citations. Rand Journal of Economics, 16–38.
Hess, A. M., & Rothaermel, F. T. (2011). When are assets complementary? Star scientists, strategic alliances, and innovation in the pharmaceutical industry. Strategic Management Journal, 32(8), 895–909.
Hsu, P., Huang, S., Massa, M., & Zhang, H. (2014). The new lyrics of the old folks: The role of family ownership in corporate innovation (Working paper). INSEAD.
Jaffe, A. B., Trajtenberg, M., & Henderson, R. (1993). Geographic localization of knowledge spillovers as evidenced by patent citations. The Quarterly Journal of Economics, 108(3), 577–598.
Jensen, M. C. (1993). The modern industrial revolution, exit, and the failure of internal control systems. The Journal of Finance, 48(3), 831–880.
Jensen, M. C., & Meckling, W. H. (1976). Theory of the firm: Managerial behavior, agency costs and ownership structure. Journal of Financial Economics, 3(4), 305–360.
Kraiczy, N. D., Hack, A., & Kellermanns, F. W. (2015). What makes a family firm innovative? CEO risk-taking propensity and the organizational context of family firms. Journal of Product Innovation Management, 32(3), 334–348.
Kraiczy, N. D., Hack, A., & Kellermanns, F. W. (2014). New product portfolio performance in family firms. Journal of Business Research, 67(6), 1065–1073.
Krause, R. (2017). Being the CEO’s boss: An examination of board chair orientations. Strategic Management Journal, 38, 697–713.
Krause, R., & Semadeni, M. (2013). Apprentice, departure, and demotion: An examination of the three types of CEO-board chair separation. Academy of Management Journal, 56(3), 805–826.
Kuhn, T. S. (1962). The structure of scientific revolutions. Chicago University Press.
La Porta, R., Lopez-de-Silanes, F., & Shleifer, A. (1999). Corporate ownership around the world. Journal of Finance, 54(2), 471–517.
Le Breton-Miller, I., Miller, D., & and Lester, R. H. (2011). Stewardship or agency? A social embeddedness reconciliation. Organization Science, 22(3), 704–721.
Lee, J., & Berente, N. (2012). Digital innovation and the division of innovative labor: Digital controls in the automotive industry. Organization Science, 23(5), 1428–1447.
Lerner, J. (1994). The importance of patent scope: An empirical analysis. The Rand Journal of Economics, 319–333.
Levin, R. C., Klevorick, A. K., Nelson, R. R., Winter, S. G., Gilbert, R., & Griliches, Z. (1987). Appropriating the returns from industrial research and development. Brookings Papers on Economic Activity, 3, 783–831.
Lodh, S., Nandy, M., & Chen, J. (2014). Innovation and family ownership: Empirical evidence from India. Corporate Governance—An International Review, 22(1), 4–23.
Matzler, K., Veider, V., Hautz, J., & Stadler, C. (2015). The impact of family ownership, management, and governance on innovation. Journal of Product Innovation Management, 32(3), 319–333.
Maury, B. (2006). Family ownership and firm performance: Empirical evidence from Western European corporations. Journal of Corporate Finance, 12(2), 321–341.
McConaughy, D. L., Matthews, C. H., & Fialko, A. S. (2001). Founding family controlled firms: Performance, risk, and value. Journal of Small Business Management, 39(1), 31–49.
Miller, D., Minichilli, A., & Corbetta, G. (2013). Is family leadership always beneficial? Strategic Management Journal, 34(5), 553–571. doi:10.1002/smj.2024.
Miller, D., Le Breton-Miller, I., Lester, R. H., & Cannella, A. A. (2007). Are family firms really superior performers?. Journal of Corporate Finance, 13(5), 829–858.
Mishra, C. S., & McConaughy, D. C. (1999). Founding family control and capital structure: The risk of loss of control and the aversion to debt. Entrepreneurship Theory and Practice, 23, 53–65.
Munari, F., Oriani, R., & Sobrero, M. (2010). The effects of owner identity and external governance systems on R&D investments: A study of western european firms, Research Policy, 39(8), 1093–1104.
Nerkar, A., & Paruchuri, S. (2005). Evolution of R&D capabilities: The role of knowledge networks within a firm. Management Science, 51(5), 771–785.
Nieto, M. J., Santamaria, L., & Fernandez, Z. (2015). Understanding the innovation behavior of family firms. Journal of Small Business Management, 53(2), 382–399.
OECD. (2011). Technology-science linkages. In OECD science, technology and industry scoreboard 2011. OECD Publishing. http://dx.doi.org/10.1787/sti_scoreboard-2011-25-en.
Patel, P. C., & Chrisman, J. J. (2014). Risk abatement as a strategy for R&D investments in family firms. Strategic Management Journal, 35, 617–627.
Penner-Hahn, J., & Shaver, J. M. (2005). Does international research and development increase patent output? An analysis of Japanese pharmaceutical firms. Strategic Management Journal, 26(2), 121–140.
Perri, A., & Andersson, U. (2014). Knowledge outflows from foreign subsidiaries and the tension between knowledge creation and knowledge protection: Evidence from the semiconductor industry. International Business Review, 23(1), 63–75.
Perri, A., Scalera, V. G., & Mudambi, R. (2017). What are the most promising conduits for foreign knowledge inflows? Innovation networks in the Chinese pharmaceutical industry. Industrial and Corporate Change, 26(2), 333–355.
Phene, A., & Almeida, P. (2008). Innovation in multinational subsidiaries: The role of knowledge assimilation and subsidiary capabilities. Journal of International Business Studies, 39, 901–919.
Rosenberg, N. (1982). Inside the black box: Technology and economics. Cambridge University Press.
Scalera, G. V., Mukherjee, D., Perri, A., & Mudambi, R. (2014). A longitudinal study of MNE innovation: The case of Goodyear. Multinational Business Review, 22(3), 270–293.
Schmid, T., Achleitner, A. K., Ampenberger, M., & Kaserer, C. (2014). Family firms and R&D behavior–New evidence from a large-scale survey. Research Policy, 43(1), 233–244.
Schmid, T., Ampenberger, M., Kaserer, C., & Achleitner, A. K. (2015). Family firm heterogeneity and corporate policy: Evidence from diversification decisions. Corporate Governance: An International Review, 23(3), 285–302.
Schulze, W. S., Lubatkin, M. H., Dino, R. N., & Buchholtz, A. K. (2001). Agency relationships in family firms: Theory and evidence. Organization Science, 12(2), 99–116.
Sirmon, D. G., & Hitt, M. A. (2003). Managing resources: Linking unique resources, management, and wealth creation in family firms. Entrepreneurship Theory and Practice, 27(4), 339–358.
Spriggs, M., Yu, A., Deeds, D., & Sorenson, R. L. (2013). Too many cooks in the kitchen: Innovative capacity, collaborative network orientation, and performance in small family businesses. Family Business Review, 26(1), 32–50.
Teece, D. J., Pisano, G., & Shuen, A. (1997). Dynamic capabilities and strategic management. Strategic Management Journal, 18(7), 509–533.
Tijssen, R. J. (2001). Global and domestic utilization of industrial relevant science: Patent citation analysis of science–technology interactions and knowledge flows. Research Policy, 30, 35–54.
Trajtenberg, M. (1990). A penny for your quotes: Patent citations and the value of innovations. The Rand Journal of Economics, 172–187.
Trajtenberg, M., Henderson, R., & Jaffe, A. (1997). University versus corporate patents: A window on the basicness of invention. Economics of Innovation and New Technology, 5(1), 19–50.
Vanhaverbeke, W., Chesbrough, H., & West, J. (2014). Surfing the new wave of open innovation research. New Frontiers in Open Innovation, 281.
Villalonga, B., & Amit, R. (2006). How do family ownership, control and management affect firm value? Journal of Financial Economics, 80(2), 385–417.
Villalonga, B., & Amit, R. (2009). How are US family firms controlled? Review of Financial Studies, 22, 3047–3091.
Wadhwa, A., & Kotha, S. (2006). Knowledge creation through external venturing: Evidence from the telecommunications equipment manufacturing industry. Academy of Management Journal, 49(4), 819–835.
Wiseman, R. M., & Gomez-Mejia L. M. (1998). A behavioral agency model of managerial risk taking. The Academy of Management Review, 23(1), 133–153.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2017 The Author(s)
About this chapter
Cite this chapter
Perri, A., Peruffo, E. (2017). Family Business and Technological Innovation: Evidence from the Italian Pharmaceutical Industry. In: Family Business and Technological Innovation. Palgrave Macmillan, Cham. https://doi.org/10.1007/978-3-319-61596-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-61596-7_5
Published:
Publisher Name: Palgrave Macmillan, Cham
Print ISBN: 978-3-319-61595-0
Online ISBN: 978-3-319-61596-7
eBook Packages: Business and ManagementBusiness and Management (R0)